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Dietary supplements derived from cartilage and medi-
cations containing sulfated amino sugars, are used with
increasing frequency by individuals affected with osteo-
arthritis (OA). Our lack of knowledge regarding their mode
of action is further complicated by the fact that many of
these compounds have to be degraded by the intestinal
flora for absorption. The metabolic studies performed in this
work suggest that the sulfate moiety present in these
molecules may be overcoming a dietary deficiency of sulfur
amino acids (SAA; cysteine and methionine), our primary
sources of sulfate. The compounds tested are rapidly
converted into free sulfate before or after absorption,
depending on their chemical nature, and excreted quanti-
tatively when the intake of protein seems to exceed
the dietary requirement for the SAA. At lower levels of
protein intake, sulfur is retained and excretion considerably
reduced.
Cartilage is a unique tissue that after acquiring its full
complement of cells during early development expands in
size by deposition of collagen type II, and tissue specific
glycosaminoglycans (GAG) that require a source of in-
organic sulfate for their synthesis. After maturity, the turn-
over of these molecules is very limited. Classical studies
by Mankin and Maroundas estimated a T1/2 of 3.5 years for
some proteoglycan fractions and 25 years for most
others1–3. Sub-optimal amounts of SAA, our major sources
of inorganic sulfate used for the de novo synthesis of GAG,
may not cause any significant problem to healthy cartilage,
but when OA begins to progress could lead to serious
consequences. During the onset of disease GAG turnover
is greatly enhanced, as evidenced by the rapid loss of
metachromasia. It is at this time, that it becomes critical to
be able to replace the matrix components, particularly the
GAG which seems to be most vulnerable to degradation. In
the context of this study it seemed to us rather coincidental
that essentially all the dietary supplements as well as many
medications claimed or shown to alleviate symptoms of
OA contain large amounts of sulfur (chondroitin sulfate,
glucosamine sulfate, SAMe (S-adenosyl methionine), MSM
(methyl-sulfonyl-methane) etc.).
The requirements for essential amino acids established
over 50 years ago in young college students, takes only
into account the amounts needed to restore nitrogen bal-
ance4,5, yet it should be readily apparent that the SAA are
in a class of their own. In addition to being building blocks
for proteins, they are the primary source of sulfur used in
the synthesis of many key metabolic intermediates as well
as GAG, main components of the extracellular matrix.
These facts led us to believe that dietary sulfur may play
an important role in the progression of OA and that the
recommended dietary allowance (RDA) for SAA methio-
nine and cysteine may underestimate the body needs for
these mutually complementary essential nutrients, particu-
larly during periods of increased synthesis, in the aged,
malnourished and individuals with joint pains who are using
acetaminophen, since 40% of this medication is excreted in
the urine conjugated with sulfate.
With this in mind we decided to investigate the relation-
ship between dietary levels of protein and urinary excretion
of sulfate during the administration of a single supplement
of 10 mmoles of L-methionine, to try and fill a gap in our
limited knowledge on sulfur balance. This study was fol-
lowed by another one where dietary supplements were
used in equivalent molar amounts. Subjects were normal
human volunteers, aged 41–70, who were instructed to
record their dietary intake and to carefully save aliquots
of their urinary output. Sulfate (free and esterified) was
measured by a modification of the nephelometric method of
Berglund and Sorbo6 and levels of SAA intake evaluated
using a Nutritional Analysis Software (ESHA Research,
version 7.6). L-Methionine (Solgar, Leonia NJ), chondroitin
sulfate (Sigma) and glucosamine sulfate (Metagenics, San
Clemente, CA) were purchased. By chemical analysis it
was found that 52% of the glucosamine was sulfated (11
tablets of 500 mg each supplied 10 mmoles of sulfate).
Patients were adapted to a particular level of dietary protein
by starting them on their diets at least 24 h in advance of
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the actual test. Protein levels were incremented by the
addition of low-fat tuna, which is mostly protein (94% of dry
weight is protein), to the basal diet.
Figure 1A summarizes sulfur balance studies which
include L-methionine supplements. The dietary SAA intake
of group II, 1.1 g or 8 mmoles, before including the supple-
ment, is consistent with the RDA of the National Academy
of Sciences (1989). Protein levels in groups IV and V, on
the other hand, are more consistent with the higher require-
ments of older individuals measured in a VA Hospital
setting (2.8–3.0 g or approximately 26 mmoles)7, a value
also reached by group III after including the supplement. It
is apparent that only those individuals consuming the
higher levels of dietary SAA tended to quantitatively excrete
the methionine supplement as urinary sulfate. Lower con-
sumption of protein was accompanied by sulfate retention,
which we suspect as part of a sparing mechanism associ-
ated with inadequate intake of SAA. The small percent of
ester sulfate excreted was disregarded, as none of these
individuals were on medications.
A similar study, using chondroitin sulfate as a dietary
source of sulfur, produced equivalent results [Fig. 1(B)].
Only at the higher levels of dietary protein is the chondroitin
sulfate supplement excreted in the urine as inorganic
sulfate. Inorganic sulfate derived from chondroitin sulfate is
never quantitatively excreted in this group, probably be-
cause it is only partially degraded by the intestinal flora to
inorganic sulfate, a pre-requisite for absorption. Studies
performed over 70 years ago by Neuberger and Hoffman
and later by Dohlman8 showed that bacterial sulfatases
were necessary to release the sulfate moiety of chondroitin
sulfate and that rats receiving sulfa and antibiotics, which
destroyed their intestinal flora, were not able to absorb
chondroitin sulfate given orally. All glucosamine sulfate is
essentially excreted in the urine as inorganic sulfate (group
V). This observation confirms recent findings showing
that sulfate concentrations in serum and synovial fluid
increased significantly in individuals 3 h after receiving
glucosamine sulfate9. It is important to note that this
response was reversed by concomitant acetaminophen
Fig. 1. Intake of SAA as part of the basic diet (dark bar) superimposed by the 10 mmoles supplement administered separately as a single
dose on the morning of the experiment. Total height of the bar represents the total intake of SAA in millimoles. Urinary output of free inorganic
sulfate included the standard error for four to five separate determinations. (A) L-Methionine supplement. (B) Chondroitin sulfate supplement
(groups I–IV) and glucosamine sulfate supplement (group V).
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administration. A lesser and non-significant increment was
noted 3 h after 3.5 mmoles of anhydrous sodium sulfate
was administered. Our experience shows that if a similar
amount of inorganic sulfate is administered during the
consumption of a diet rich in SAA, it will be excreted in a
quantitative fashion over a 24 hour period. If on the other
hand protein levels are inadequate sulfate will be retained.
Although these findings strongly support the idea that the
RDA for SAA are underestimated by using N-balance as a
criteria, the significantly higher values that we observed
could slightly overestimate requirements. Subjects were
placed on marginal protein diets for up to 96 h prior to
the initiation of the study, which could of depleted sulfur
storages, such as glutathione, and enhanced sulfur
retention.
It should be pointed out, for purpose of comparison, that
the dietary SAA intake in a normal population ranges
between 1.8 and 6.0 g of SAA/day (14–45 mmoles). A
preliminary evaluation that we performed on 34 individuals
fell within these values. The lower ranges, in the vicinity of
2.6 g/day, was achieved by vegetarians and individuals
who restrict their animal protein consumption to small
portions of chicken or fish and consume little or no red
meats, quite fashionable nowadays.
Our metabolic data extends the suggestions that sulfate
may mediate the therapeutic effects of glucosamine sul-
fate9 to other sulfur containing compounds. It also suggests
that the requirements for SAA should be reevaluated, not
necessarily in the context of protein synthesis using the
classical nitrogen balance approach, for which the current
estimates will most likely hold, but for their ability to provide
sufficient sulfur for the synthesis of proteoglycans and other
important S-containing metabolic intermediates (coenzyme
A, S-adenosyl methionine, glutathione, etc.), all of which
play an important role in cell, and in particular, chondrocyte
metabolism. Recent findings from the Framingham osteo-
porosis study10 further support this line of thought, since
individuals consuming a low protein intake presented with
significantly less bone at femoral and spine sites.
It should also be noted that sulfate depletion inhibits
GAG synthesis by rat and human articular cartilage, human
articular cartilage being particularly susceptible11. The ex-
tracellular sulfate pool in humans is amongst the smallest
of all species investigated12, one reason probably being
that the precursor-free sulfhydro groups are cytotoxic. This,
therefore, requires a rather sustained supply of dietary
sulfur. In summary, our findings offer a plausible expla-
nation for the mode of action of chondroprotective com-
pounds. By serving as a source of inorganic sulfur, they
may be compensating for a sub-optimal or marginal intake
of SAA. These studies suggest the possibility that increas-
ing the intake of dietary protein of high biological value, or
the regular consumption throughout the day of certain
mineral waters, some of which contain around 0.5 g/l of
inorganic sulfate, may prove to have effects similar to those
derived from the administration of the sulfur containing
compounds in question. It is recommended that the dietary
intake of sulfur be monitored in studies designed to evalu-
ate the efficacy of chondroprotective compounds, as it is
possible that the individuals who benefit the most from
them may be those with marginal protein intake.
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